Animal models for viral haemorrhagic fever

被引:12
|
作者
Falzaran, D. [1 ,2 ]
Bente, D. A. [1 ]
机构
[1] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Programme, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
关键词
RIFT-VALLEY FEVER; LASSA VIRUS-INFECTION; FOREST-DISEASE VIRUS; RHESUS-MONKEY MODEL; PROTECT GUINEA-PIGS; EBOLA-VIRUS; YELLOW-FEVER; DENGUE VIRUS; MOUSE MODEL; COMPARATIVE PHYSIOLOGY;
D O I
10.1111/1469-0691.12630
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Viral haemorrhagic fever can be caused by one of a diverse group of viruses that come from four different families of RNA viruses. Disease severity can vary from mild self-limiting febrile illness to severe disease characterized by high fever, high-level viraemia, increased vascular permeability that can progress to shock, multi-organ failure and death. Despite the urgent need, effective treatments and preventative vaccines are currently lacking for the majority of these viruses. A number of factors preclude the effective study of these diseases in humans including the high virulence of the agents involved, the sporadic nature of outbreaks of these viruses, which are typically in geographically isolated areas with under-serviced diagnostic capabilities, and the requirements for high level bio-containment. As a result, animal models that accurately mimic human disease are essential for advancing our understanding of the pathogenesis of viral haemorrhagic fevers. Moreover, animal models for viral haemorrhagic fevers are necessary to test vaccines and therapeutic intervention strategies. Here, we present an overview of the animal models that have been established for each of the haemorrhagic fever viruses and identify which aspects of human disease are modelled. Furthermore, we discuss how experimental design considerations, such as choice of species and virus strain as well as route and dose of inoculation, have an influence on animal model development. We also bring attention to some of the pitfalls that need to be avoided when extrapolating results from animal models. (C) 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
引用
收藏
页码:E17 / E27
页数:11
相关论文
共 50 条
  • [31] Emerging viral infections - Crimean-Congo haemorrhagic fever in Turkey
    Ergonul, O.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S2 - S2
  • [32] The earliest description of possible viral haemorrhagic fever identified in ancient Greece
    Ashrafian, Hutan
    JOURNAL OF TRAVEL MEDICINE, 2024, 31 (02)
  • [33] DEVELOPMENT OF SPATIAL SURVEILLANCE MODELS FOR DENGUE FEVER AND DENGUE HAEMORRHAGIC FEVER PREVENTION AND CONTROL
    Suksai, Surasak
    Sarapirome, Sunya
    SURANAREE JOURNAL OF SCIENCE AND TECHNOLOGY, 2012, 19 (03): : 203 - 214
  • [34] Humanitarian nursing in a viral haemorrhagic fever outbreak: before, during and after deployment
    Paillard-Borg, S.
    Saaristo, P.
    von Strauss, E.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 203 - 203
  • [35] Initial medical and antiepidemic measures applied to cases with suspected viral haemorrhagic fever
    Fock, R
    Koch, U
    Wirtz, A
    Peters, M
    Ruf, B
    Grünewald, T
    MEDIZINISCHE WELT, 2001, 52 (05): : 126 - 132
  • [36] Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome
    Korva, M.
    Saksida, A.
    Kejzar, N.
    Schmaljohn, C.
    Avsic-Zupanc, T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (08) : 778 - 778
  • [37] Taurolithocholic acid protects against viral haemorrhagic fever via inhibition of ferroptosis
    Zheng, Xiaojie
    Zhang, Yunfa
    Zhang, Lingyu
    Yang, Tong
    Zhang, Faxue
    Wang, Xi
    Zhu, Shu Jeffrey
    Cui, Ning
    Lv, Hongdi
    Zhang, Xiaoai
    Li, Hao
    Liu, Wei
    NATURE MICROBIOLOGY, 2024, 9 (10): : 2583 - 2599
  • [38] Gene optimization for expression of Crimean-Congo haemorrhagic fever viral nucleoprotein
    Samudzi, R.
    Burt, F. J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E47 - E47
  • [39] Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda
    Shoemaker, Trevor R.
    Balinandi, Stephen
    Tumusiime, Alex
    Nyakarahuka, Luke
    Lutwama, Julius
    Mbidde, Edward
    Kofman, Aaron
    Klena, John D.
    Stroher, Ute
    Rollin, Pierre E.
    Nichol, Stuart T.
    LANCET INFECTIOUS DISEASES, 2018, 18 (04): : 373 - 375
  • [40] Contemporary and emerging pharmacotherapeutic agents for the treatment of Lassa viral haemorrhagic fever disease
    Joseph, Adejoke Adijat
    Fasipe, Olumuyiwa John
    Joseph, Oluyemi Adesoji
    Olatunji, Olalekan Aliu
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (06) : 1525 - 1531